Par Pharmaceutical Companies, Inc. is a privately held, U.S.-based specialty pharmaceutical company that develops, manufactures and markets high-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals through its wholly-owned subsidiary’s two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals. Par is a portfolio company of TPG, a leading global private investment firm with $55.7 billion of assets under management and with extensive experience in the healthcare sector.
Editors [1]
The following is the list of scholars from PAR Sterile Products who currently serve as editors for one or more SciTechnol journals.
Publications [7]
The following is the list of articles by scholars from PAR Sterile Products that are published in SciTechnol journals.
-
Young Researchers Forum for Nano Pharmaceuticals 2020
Short Communication: J Pharm Drug Deliv Res
DOI:
Drug Metabolism,Drug Properties,Drug safety databases,Drug Targeting
-
Tetracycline Sclerotherapy for Seroma: A Systematic Review
Review Article: J Pharm Drug Deliv Res
DOI:
AlQ hatani A
-
Prodrug in Pharmaceutics
Editorial: J Pharm Drug Deliv Res
DOI:
Bivash M
-
Bioavailability and Pharmaceuticals
Editorial: J Pharm Drug Deliv Res
DOI:
Bivash M
-
2020 Market Analysis of Pharmaceutical Formulations & Drug Delivery Conference October 30-31, 2020 | Vancouver, Canada
Short Communication: J Pharm Drug Deliv Res
DOI:
Bodhisattwa Chaudhuri
-
Development of Simple, Facile Spectrophotometric Method for Determination of Metformin Hydrochloride in Aqueous Medium
Research Article: J Pharm Drug Deliv Res, 9:1
DOI:
Sonali Garg, Pratima Sharma, Dhiraj Sud .
-
Journal of Pharmaceutics and Drug Delivery Research
Editorial: J Pharm Drug Deliv Res
DOI:
Neil Foster